Join Professor Gary Middleton and Dr. Akshay Patel from the University of Birmingham as they discuss:

      • Immune-related adverse events following checkpoint blockade
      • The role of the humoral immune system in understanding response to treatment
      • The mechanisms underpinning development of irAEs and their relevance for stratifying patients at risk of toxicity and improving long-term treatment outcomes